BR9707304A - Análogos de nucleosídeos em terapia de combinação de infecções de herpes simples - Google Patents

Análogos de nucleosídeos em terapia de combinação de infecções de herpes simples

Info

Publication number
BR9707304A
BR9707304A BR9707304A BR9707304A BR9707304A BR 9707304 A BR9707304 A BR 9707304A BR 9707304 A BR9707304 A BR 9707304A BR 9707304 A BR9707304 A BR 9707304A BR 9707304 A BR9707304 A BR 9707304A
Authority
BR
Brazil
Prior art keywords
combination therapy
herpes simplex
nucleoside analogues
simplex infections
infections
Prior art date
Application number
BR9707304A
Other languages
English (en)
Inventor
Malcolm Richard Boyd
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10787583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9707304(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9707304A publication Critical patent/BR9707304A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR9707304A 1996-01-26 1997-01-24 Análogos de nucleosídeos em terapia de combinação de infecções de herpes simples BR9707304A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601544.1A GB9601544D0 (en) 1996-01-26 1996-01-26 Pharmaceuticals
PCT/GB1997/000226 WO1997026882A1 (en) 1996-01-26 1997-01-24 Nucleoside analogs in combination therapy of herpes simplex infections

Publications (1)

Publication Number Publication Date
BR9707304A true BR9707304A (pt) 1999-07-20

Family

ID=10787583

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707304A BR9707304A (pt) 1996-01-26 1997-01-24 Análogos de nucleosídeos em terapia de combinação de infecções de herpes simples

Country Status (26)

Country Link
US (5) US6514980B1 (pt)
EP (1) EP0876146B1 (pt)
JP (1) JP2000507211A (pt)
KR (1) KR19990081966A (pt)
CN (1) CN1133433C (pt)
AR (1) AR005551A1 (pt)
AT (1) ATE238796T1 (pt)
AU (1) AU713202B2 (pt)
BR (1) BR9707304A (pt)
CY (1) CY2421B1 (pt)
CZ (1) CZ297841B6 (pt)
DE (1) DE69721484T2 (pt)
DK (1) DK0876146T3 (pt)
ES (1) ES2199339T3 (pt)
GB (1) GB9601544D0 (pt)
HK (1) HK1016475A1 (pt)
HU (1) HU226793B1 (pt)
IL (1) IL125075A (pt)
NO (1) NO316355B1 (pt)
NZ (1) NZ326839A (pt)
PL (1) PL187076B1 (pt)
PT (1) PT876146E (pt)
TR (1) TR199801439T2 (pt)
TW (1) TW493985B (pt)
WO (1) WO1997026882A1 (pt)
ZA (1) ZA97608B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ1966A1 (fr) 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7591945B2 (en) * 2003-02-07 2009-09-22 Gambro Lundia Ab Support device for containers in extracorporeal blood treatment machines
CA2602562C (en) * 2005-03-25 2015-07-07 Alt Solutions, Inc. Modulation of telomere length in telomerase positive cells and cancer therapy
CA2609303A1 (en) * 2005-05-18 2006-11-23 Alt Solutions, Inc. Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
GB201907305D0 (en) * 2019-05-23 2019-07-10 Douglas Pharmaceuticals Ltd Treatment of conditions
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US3322627A (en) * 1964-09-03 1967-05-30 Merck & Co Inc Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
DE69306545T2 (de) 1992-10-01 1997-04-03 Wellcome Found Tucaresol als Mittel zur Immunopotentierung
GB9426021D0 (en) 1994-12-22 1995-02-22 Smithkline Beecham Plc Pharmaceuticals
DZ1966A1 (fr) * 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections

Also Published As

Publication number Publication date
PL327917A1 (en) 1999-01-04
DE69721484T2 (de) 2004-02-26
TR199801439T2 (xx) 1998-10-21
JP2000507211A (ja) 2000-06-13
NO983402L (no) 1998-07-23
CN1133433C (zh) 2004-01-07
HUP9900945A3 (en) 2001-02-28
CZ297841B6 (cs) 2007-04-11
ATE238796T1 (de) 2003-05-15
HK1016475A1 (en) 1999-11-05
AU713202B2 (en) 1999-11-25
ES2199339T3 (es) 2004-02-16
GB9601544D0 (en) 1996-03-27
PL187076B1 (pl) 2004-05-31
EP0876146A1 (en) 1998-11-11
CZ234098A3 (cs) 1999-02-17
WO1997026882A1 (en) 1997-07-31
US20100323952A1 (en) 2010-12-23
US20050222016A1 (en) 2005-10-06
NZ326839A (en) 2001-02-23
EP0876146B1 (en) 2003-05-02
IL125075A (en) 2003-02-12
DK0876146T3 (da) 2003-08-11
IL125075A0 (en) 1999-01-26
ZA97608B (en) 1998-07-24
AU1550697A (en) 1997-08-20
DE69721484D1 (de) 2003-06-05
CN1209748A (zh) 1999-03-03
TW493985B (en) 2002-07-11
US20080287389A1 (en) 2008-11-20
KR19990081966A (ko) 1999-11-15
US20040185433A1 (en) 2004-09-23
HUP9900945A2 (hu) 1999-07-28
HU226793B1 (en) 2009-10-28
US6514980B1 (en) 2003-02-04
NO316355B1 (no) 2004-01-19
NO983402D0 (no) 1998-07-23
CY2421B1 (en) 2004-11-12
PT876146E (pt) 2003-09-30
AR005551A1 (es) 1999-06-23

Similar Documents

Publication Publication Date Title
GB9602028D0 (en) Nucleoside analogues
PT880533E (pt) Derivados de triazole uteis em terapia
IT1271508B (it) Chiodo endomidollare bloccato adatto in particolare per omero
BR9304554A (pt) Aperfeiçoamento em eixos de traçâo em tandem
GB2340491B (en) Carbocyclic nucleoside hemisulfate and its use in treating viral infections
BR9707304A (pt) Análogos de nucleosídeos em terapia de combinação de infecções de herpes simples
BR9503471A (pt) Aperfeiçoamento em veiculo de trabalho
DK0850246T3 (da) Pyrimidinnukleosidderivater
SI0876146T1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
BR7302397U (pt) Disposição introduzida em carrinho de pedreiro
KR950007076U (ko) 좌석버스용 요금함
BR7501644U (pt) Cavalete para automóveis em geral
BR7301193U (pt) Disposição introduzida em janela para ônibus.
BR7500597U (pt) Disposição introduzida em aerofólios
BR9702561A (pt) Aperfeiçoamento em mecanismo de fixação
BR7703004U (pt) Disposição introduzida em calceiros
BR7400382U (pt) Disposição introduzida em batoque corta-fluxo para frascos diversos
DK98093D0 (da) Herpesmiddel
BR9300978A (pt) Aperfeicoamento em abracadeira
BR7302089U (pt) Disposição introduzida em calceiro
BR7300103U (pt) Aperfeiçoamento em forrageira-ensiladeira
BR7300655U (pt) Aperfeiçoamento em palmiha
BR7301739U (pt) Aperfeiçoamento em telealarme
BR7301930U (pt) Disposiçao introduzida em telha
BR9505746A (pt) Aperfeiçoamento em caixa de ferramentas

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM)

Free format text: TRANSFERIDO DE: SMITHKLINE BEECHAM P.L.C

B12B Appeal against refusal [chapter 12.2 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: ARQUIVAMENTO DEFINITIVO

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2295 DE 30/12/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ATE A 23A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.